openPR Logo
Press release

Pouchitis Treatment Market Size Estimated to Observe Significant Growth by 2025

06-19-2018 06:36 PM CET | Health & Medicine

Press release from: Transparency Market Research

Pouchitis Treatment Market Size Estimated to Observe

Pouchitis is an inflammatory condition of the ileal pouch. It happens when the ileal pouch reservoir becomes inflamed or irritated. Pouchitis mainly occurs in a patient who has undergone ileal pouch-anal anastomosis (IPAA), a surgical procedure for removing the rectum and the large intestine. About half of the number of patients who undergo this surgery develops pouchitis at least once in their lifetime. Every year, up to 40% of patients who undergo IPAA surgery develops pouchitis. However, the exact cause of pouchitis has not yet been determined. Pouchitis has been observed occurring among patients suffering from ulcerative colitis or some other form of colitis, and also rarely among patients with genetic condition (familial adenomatous polyposis), in which many polyps are formed in the colon. Other factors responsible for the development of pouchitis include backwash ileitis, long-term usage of non-steroidal anti-inflammatory drugs (NSAIDs), increased number of platelets, smoking, and health conditions such as diabetes or heart disease. Common symptoms of pouchitis include tenesmus, straining during defecation, blood in stool, seepage of waste matter while asleep, incontinence, tail bone pain, abdominal cramp, and increased frequency in night-time bowel movements.

Options presently available for the treatment of pouchitis include antibiotics, budesonide enemas, probiotics, glutamine suppositories, butyrate suppositories, bismuth enemas, allopurinol, and tinidazole. The global Pouchitis Treatment Market is expected to expand at a significant CAGR during the forecast period as there is not a single therapy has been approved in the US and Europe for the treatment of pouchitis. However, a few pipeline molecules are waiting for approval, such as alicaforsen, the molecule developed by Atlantic Healthcare plc. Rise in the prevalence of ulcerative colitis, increase in the number of ileal pouch-anal anastomosis procedure, long-term usage of non-steroidal anti-inflammatory drugs, and growth in the geriatric population are the key factors driving the global pouchitis treatment market. However, disappointing result of promising pipeline molecules and stringent government regulations are anticipated to hamper the growth of the global pouchitis treatment market during the forecast period.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=42062

Geographically, the global pouchitis treatment market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America, followed by Europe, is anticipated to be a dominant pouchitis treatment market for pouchitis treatment during the forecast period. High incidence of pouchitis, rise in the number of patients undergoing ileal pouch-anal anastomosis, increase in R&D expenditure, ongoing intensive research on bowel complications, and well-established healthcare infrastructure, among other factors contribute to the growth of the pouchitis treatment market in North America. The pouchitis treatment market in Asia Pacific is anticipated to expand at a significant CAGR during the forecast period, the growth being primarily driven by India and China owing to the large patient base undergoing ileal pouch-anal anastomosis, increased incidence of ulcerative colitis, rise in awareness regarding the disease, increased government initiatives toward healthcare, and developing healthcare infrastructure in these countries. The pouchitis treatment market in Latin America and Middle East & Africa is anticipated to expand during the forecast period due to rise in prevalence of pouchitis and upsurge in investments by pouchitis treatment market players in these regions.

The leading players in the global pouchitis treatment market include Atlantic Healthcare, Pfizer, Allergan Plc, Abbott, Alfa sigma, Bayer, Takeda Pharmaceutical Company Limited, AstraZeneca, Tillotts Pharma AG, Novartis AG, Astellas Pharma Inc., Synergy Pharmaceuticals, Inc., Valeant Pharmaceuticals, Sucampo Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Sebela Pharmaceuticals, Sanofi, Ironwood Pharmaceuticals, Inc., Ardelyx, Inc., and Probi.

View Report -

https://www.transparencymarketresearch.com/pouchitis-treatment-market.html

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pouchitis Treatment Market Size Estimated to Observe Significant Growth by 2025 here

News-ID: 1089186 • Views: 378

More Releases from Transparency Market Research

Impact of Outbreak of COVID-19 on Medical Education Market : Global Industry Ana …
Transparency Market Research (TMR) has published a new report on the medical education market for the period of 2019–2027. According to the report, the global medical education market was valued at nearly US$ 31 Bn in 2018, and is projected to expand at a CAGR of more than 4% from 2019 to 2027. Rise in the number of medical schools and increase in cost of medical education are the
Healthcare BI Platform Market Companies Analysis, Advancement and Precise Outloo …
In an intensely competitive healthcare business intelligence (BI) platform market, large players are aggressively focused on expanding their geographical outreach, says Transparency Market Research (TMR) in a new market intelligence report. These large players are leveraging the cloud business model to provide healthcare BI solutions that can be accessed irrespective of location. Apart from this, savvy players are entering into partnerships with hospital groups and healthcare bodies to integrate healthcare BI
Substance Abuse Treatment Market News Research Report 2024
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their
Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Siz …
Clinical Oncology Next Generation Sequencing: Introduction Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy. Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15

All 5 Releases


More Releases for Pharma

Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Clomifene Citrate Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Clomifene Citrate Market" across the global, regional and country level. The report provides 360° analysis of "Clomifene Citrate Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Clomifene Citrate industry, and estimates the future trend of Clomifene Citrate market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business